CDH1 and urinary bladder cancer: Zuo et al. (28) demonstrated that in vitro, CERCAM overexpression significantly promoted bladder cancer cell survival, cell invasion and DNA synthesis, altering the expression patterns of N-cadherin, E-cadherin and Caspase 3; in vivo, CERCAM silencing inhibited tumor progression in mice.